Plandai Biotechnology PLPL · USD

Its shares trade under the ticker PLPL. It has been listed since 10 December 2001. In the fiscal year to 30 June 2023, it reported revenue of $298,494 and a net loss of $19.8m. At that date it held shareholders' equity of −$442,644.

Plandai Biotechnology, Inc. engages in the production of botanical extracts for the nutriceutical and pharmaceutical industries. The company is headquartered in Logan, Utah. The company went IPO on 2001-12-10. The company grows the green tea used in its Phytofare Catechin production, a 3,000-hectare estate it operates under approximately 50-years lease in the Mpumalanga province of South Africa. The company uses an extraction process that is engineered to yield bioavailable products of pharmaceutical-grade purity. The company offers Phytofare Catechin Complex, a green-tea derived extract and a commercial product in the Phytofare brand. Its principle holdings consist of land, farms and infrastructure in South Africa. Its extracts include gallate catechins from green tea, such as catechin gallate (CG), epigallocatechin gallate (EGCG), gallocatechin gallate (GCG) and epicatechin gallate (ECG), and carotenoids (lycopene) from tomatoes, as well as citrus bioflavonoids and limonoids. The company manufactures and formulates the Pheroid technology for entrapped Phytofare extracts.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Roger Baylis-DuffieldChairman of the Board, Chief Executive Officer, Chief Financial Officer, since 2011$5.3m
• Mr. Callum Cottrell DuffieldPresident, Chief Operating Officer, Vice President of Sales and Marketing, Secretary, Director$382,500
• Mr. Ezra JonesVice President of Sales and Marketing
• Mr. Jamen ShivelyVice President - Global Marketing, since 2014$9,000
• Ms. Daron DuffieldDirector$45,000
• Mr. Brian JohnsonDirector$60,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.